Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: IMbrave150 trial ×

IMbrave150 trial

This institution is selected. Its supporting articles are shown below.

IMbrave150 trial1

Articles mentioning IMbrave150 trial

1 articles · page 1 of 1

Immunotherapy in HCC: aetiology matters

egastro · abstract · 2026-05-29 · 1 matching annotations

87.4%

IMbrave150 trial atezolizumab bevacizumab immunotherapy immune checkpoint blockade HCC advanced hepatocellular carcinoma ICB

…ce the landmark success of atezolizumab plus bevacizumab in the IMbrave150 trial, immunotherapy has become the standard of care for advanced HCC…

Browse institutions

IMbrave150 trial

Articles mentioning IMbrave150 trial

Immunotherapy in HCC: aetiology matters